BYDUREON BCise Depot susp inj 2 mg auto-injecteur, , BYDUREON BCise Depot susp inj 2 mg auto-injecteur injecteur 4 pce
7680675030019
CH-67503
A10BJ01
1 / 2
google
Details
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Articles (1)
Bydureon BCise 2 mg, Depot-lnjektionssuspension in einem Autoinjektor
Depot-lnjektionssuspension in einem Autoinjektor
4
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
exenatidum
|
2.0 MG | Substance | Wirkstoff (Principe actif) |
|
saccharum
|
- | Substance | HNIDK |
|
poly(lactidum-co-glycolidum) 50/50 (0.40 - 0.49 dl/g)
|
- | Substance | HNIDK |
|
triglycerida media
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 114.90
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/02/2021
Authorization holder
AstraZeneca AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 67503
- Drug name
- Bydureon BCise, Depot-lnjektionssuspension in einem Autoinjektor
- Galenic form
- DEPI
- ATC Code
- A10BJ01
- Authorization status
- Revoked/Withdrawn
- Dispensation category
- B
- First authorization
- 24/09/2020
- Authorization expiration date
- 01/07/2026
- IT number
- 07.06.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BYDUREON BCise Depot 2 mg auto-injecteur 4 pce
- Description (DE)
- BYDUREON BCise Depot 2 mg Autoinjektor 4 Stk
- Market launch
- 24/09/2020
- Market withdrawal
- 30/06/2026
- Narcotic (BTM)
- No